4 結果
FIELD OF THE INVENTION
The present invention relates to the optical isomers of a spiroquinuclidine derivative, to pharmaceutical compositions comprising such isomers, to a method for treating diseases of the central nervous system therewith and to a process for preparing said isomers.
BACKGROUND OF
FIELD OF THE INVENTION
This invention relates to a memory enhancing and anti-dementia agent containing dehydroevodiamine-HCl as an active ingredient, expressed by the following formula (I), and more particularly, to use, as an anti-dementia agent, of a pharmaceutical containing
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition or a composition for health foods containing preparation plant extracts or a mixture thereof as an active ingredient for preventing and treating dementia, Parkinson's disease, or epilepsy.
BACKGROUND ART
When considering a
FIELD OF THE INVENTION
The present invention is related to the use of an extract containing derivatives of succinate esters from Wangla (Coeloglossum viride (L) Hartm. Var. Bracteatum (Wild.) Richter), synthetic derivatives of succinate esters, and pharmaceutical acceptable salts thereof in the